Neuraxis Inc./$NRXS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Neuraxis Inc.
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
- Ticker
- $NRXS
- Sector
- Health
- Primary listing
- AMEX
- Employees
- 24
- Headquarters
- Carmel, United States
- Website
- neuraxis.com
Neuraxis Inc. Metrics
BasicAdvanced
$64M
-
-$1.10
1.38
-
Price and volume
Market cap
$64M
Beta
1.38
52-week high
$9.33
52-week low
$2.21
Average daily volume
177K
Financial strength
Current ratio
2.096
Quick ratio
1.83
Long term debt to equity
0.04
Total debt to equity
0.118
Interest coverage (TTM)
-128.36%
Profitability
EBITDA (TTM)
-12.087
Gross margin (TTM)
86.16%
Net profit margin (TTM)
-185.24%
Operating margin (TTM)
-186.16%
Revenue per employee (TTM)
$270,000
Management effectiveness
Return on assets (TTM)
-122.28%
Return on equity (TTM)
-409.70%
Valuation
Price to revenue (TTM)
8.043
Price to book
17.17
Price to tangible book (TTM)
18.52
Price to free cash flow (TTM)
-7.975
Free cash flow yield (TTM)
-12.54%
Free cash flow per share (TTM)
-0.564
Growth
Revenue change (TTM)
94.29%
Earnings per share change (TTM)
9.17%
3-year revenue growth (CAGR)
36.98%
3-year earnings per share growth (CAGR)
-41.25%
What the Analysts think about Neuraxis Inc.
Analyst ratings (Buy, Hold, Sell) for Neuraxis Inc. stock.
Analyst projections of the future price of Neuraxis Inc. stock.
Neuraxis Inc. Financial Performance
Revenues and expenses
Neuraxis Inc. Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.